CC BY-NC-ND 4.0 · South Asian J Cancer
DOI: 10.1055/s-0043-1771405
Original Article

Psycho-oncology/Supportive Care in Head–Neck Cancers Patients Undergoing Radiation Therapy: A Randomized Controlled Trial

Shwetabh Sinha
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Saket Pandey
2   Department of Radiation Oncology, Apollo Hospital, Lucknow, Uttar Pradesh, India
,
Shirley L. Salins
3   Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal, Karnataka, India
,
4   Department of Palliative Medicine, Kasturba Medical College, Manipal, Karnataka, India
,
Jayita Deodhar
5   Department of Palliative Medicine, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Tejpal Gupta
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Ashwini Budrukkar
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Monali Swain
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Anuj Kumar
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Vedang Murthy
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Sudhir Nair
6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Deepa Nair
6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Poonam Joshi
6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Pankaj Chaturvedi
6   Department of Head and Neck Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Vijay Patil
7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Amit Joshi
7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Kumar Prabhash
7   Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Jai Prakash Agarwal
1   Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
› Author Affiliations
Funding The trial was funded by an intramural grant from Department of Atomic Energy of India (DAE)—Clinical Trial Centre (CTC), Tata Memorial Centre.

Abstract

Zoom Image
Shwetabh Sinha

An elevated level of distress is associated with poor health-related quality of life (QoL), decreased patient satisfaction, poor treatment compliance, and possible reduced survival. This randomized trial, conducted at a single center in India, enrolled head–neck cancer patients aged > 18 years who were undergoing curative intent radiation therapy, and had significant baseline distress as per the National Comprehensive Cancer Network distress thermometer (distress score ≥ 4). The patients were randomized into the Standard arm (STD), which involved routine assessment by the oncologist, or the Interventional arm (INV), where psycho-oncology/palliative/supportive care referral was done at baseline and every week during treatment. The study's primary endpoint was the proportion of patients having significant distress 6 months' posttreatment. A total of 212 patients were randomized (n = 108 STD, n = 104 INV). At 6 months' post-treatment completion, 90 and 89 were evaluable in the STD and INV, respectively. The median distress score was 2 in both arms at this time point. There was no significant difference in the proportion of patients having significant distress in STD versus INV (9 vs. 15.6%, p = 0.20). There was an improvement in any symptom measured by the Edmonton Symptom Assessment Score (pain, tiredness, drowsiness, nausea, lack of appetite) and the QoL for the entire cohort with no statistically significant difference between arms for symptoms, QoL, or survival endpoints. Psycho-oncology and palliative/supportive care referral did not impact distress, symptom burden, QoL, or survival at 6 months' posttreatment completion significantly in this randomized trial.

Clinical Trial Registry of India Registration number: CTRI/2016/01/006549.

Note

The study results were presented as a proffered paper at the ESTRO 2022 conference held in Copenhagen in May 2022.




Publication History

Article published online:
31 July 2023

© 2023. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 National Comprehensive Cancer Network. Distress management. Clinical practice guidelines. J Natl Compr Canc Netw 2003; 1 (03) 344-374
  • 2 Zabora J, BrintzenhofeSzoc K, Curbed B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10 (01) 19-28
  • 3 Hamer M, Chida Y, Molloy GJ. Psychological distress and cancer mortality. J Psychosom Res 2009; 66 (03) 255-258
  • 4 Carlson LE, Bultz BD. Cancer distress screening. Needs, models, and methods. J Psychosom Res 2003; 55 (05) 403-409
  • 5 Pandey M, Devi N, Ramdas K, Krishnan R, Kumar V. Higher distress relates to poor quality of life in patients with head and neck cancer. Int J Oral Maxillofac Implants 2009; 38 (09) 955-959
  • 6 Skarstein J, Aass N, Fosså SD, Skovlund E, Dahl AA. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life questionnaire. J Psychosom Res 2000; 49 (01) 27-34
  • 7 Kennard BD, Stewart SM, Olvera R. et al. Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings 2004; 11 (01) 31-39
  • 8 Howell D, Olsen K. Distress-the 6th vital sign. Curr Oncol 2011; 18 (05) 208-210
  • 9 Cutillo A, O'Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The distress thermometer: cutoff points and clinical use. Oncol Nurs Forum 2017; 44 (03) 329-336
  • 10 Menon N, Patil V, Noronha V. et al. Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - additional data from a phase 3 trial. Oral Oncol 2021; 122: 105517
  • 11 Lewis S, Pandey S, Salins N. et al. Distress screening in head and neck cancer patients planned for cancer-directed radiotherapy. Laryngoscope 2021; 131 (09) 2023-2029
  • 12 Krebber AMH, Jansen F, Witte BI. et al. Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: a randomized, controlled trial. Ann Oncol 2016; 27 (09) 1754-1760
  • 13 Humphris GM, Ozakinci G. Psychological responses and support needs of patients following head and neck cancer. Int J Surg 2006; 4 (01) 37-44
  • 14 Badr H, Gupta V, Sikora A, Posner M. Psychological distress in patients and caregivers over the course of radiotherapy for head and neck cancer. Oral Oncol 2014; 50 (10) 1005-1011
  • 15 Tang ST, Li CY, Liao YC. Factors associated with depressive distress among Taiwanese family caregivers of cancer patients at the end of life. Palliat Med 2007; 21 (03) 249-257
  • 16 Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs [Internet]. Adler NE, Page AE, eds. Washington (DC): National Academies Press (US); 2008. (The National Academies Collection: Reports funded by National Institutes of Health). Accessed November 12, 2022 at: http://www.ncbi.nlm.nih.gov/books/NBK4015/
  • 17 Noronha V, Joshi A, Patil VM. et al. Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial. J Clin Oncol 2018; 36 (11) 1064-1072
  • 18 Sinha S, Agarwal JP, Mahajan A. et al. Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: results from a prospective study. Head Neck 2021; 43 (04) 1289-1299
  • 19 Ghosh-Laskar S, Yathiraj PH, Dutta D. et al. Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results. Head Neck 2016; 38 (Suppl. 01) E1481-E1487
  • 20 Gupta T, Agarwal J, Jain S. et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol 2012; 104 (03) 343-348
  • 21 Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol 2013; 31 (06) 782-793
  • 22 Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin 2018; 68 (02) 153-165
  • 23 de Souza JA, Wong YN. Financial distress in cancer patients. J Med Person 2013; 11 (02) DOI: 10.1007/s12682-013-0152–3.
  • 24 Singh AG, Chaukar D, Gupta S. et al. A prospective study to determine the cost of illness for oral cancer in India [Internet]. 2021. Accessed November 11, 2021 at: http://ecancer.org/en/journal/article/1252-a-prospective-study-to-determine-the-cost-of-illness-for-oral-cancer-in-india
  • 25 Chauhan AS, Prinja S, Ghoshal S, Verma R. Economic burden of head and neck cancer treatment in North India. Asian Pac J Cancer Prev 2019; 20 (02) 403-409
  • 26 Chauhan AS, Prinja S, Ghoshal S, Verma R, Oinam AS. Cost of treatment for head and neck cancer in India. PLoS One 2018; 13 (01) e0191132
  • 27 Poddar A, Aranha RRK, K. Muthukaliannan G, Nachimuthu R, Jayaraj R. Head and neck cancer risk factors in India: protocol for systematic review and meta-analysis. BMJ Open 2018; 8 (08) e020014
  • 28 Alam. Epidemiological profile of head and neck cancer patients in Western Uttar Pradesh and analysis of distributions of risk factors in relation to site of tumor [Internet]. Accessed November 11, 2021 at: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2017;volume=13;issue=3;spage=430;epage=435;aulast=Alam
  • 29 Patil VM, Singhai P, Noronha V. et al. Effect of early palliative care on quality of life of advanced head and neck cancer patients: a phase III trial. J Natl Cancer Inst 2021; 113 (09) 1228-1237
  • 30 Howell D, Molloy S, Wilkinson K. et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol 2015; 26 (09) 1846-1858
  • 31 Chang EM, Gillespie EF, Shaverdian N. Truthfulness in patient-reported outcomes: factors affecting patients' responses and impact on data quality. Patient Relat Outcome Meas 2019; 10: 171-186
  • 32 Chopra S, Gupta S, Kannan S. et al. Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol 2021; 39 (33) 3682-3692
  • 33 Temel JS, Greer JA, Muzikansky A. et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363 (08) 733-742
  • 34 Sullivan DR, Chan B, Lapidus JA. et al. Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the Veterans Health Administration. JAMA Oncol 2019; 5 (12) 1702-1709
  • 35 Scarpi E, Dall'Agata M, Zagonel V. et al; Early Palliative Care Italian Study Group (EPCISG). Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes. Support Care Cancer 2019; 27 (07) 2425-2434
  • 36 Guo Z, Tang HY, Li H. et al. The benefits of psychosocial interventions for cancer patients undergoing radiotherapy. Health Qual Life Outcomes 2013; 11 (01) 121
  • 37 Deleemans JM, Mothersill K, Bultz BD, Schulte F. Ethical considerations in screening head and neck cancer patients for psychosocial distress. Support Care Cancer 2020; 28 (02) 617-624
  • 38 Mitchell AJ. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 2010; 8 (04) 487-494
  • 39 Smith SK, Loscalzo M, Mayer C, Rosenstein DL. Best practices in oncology distress management: beyond the screen. Am Soc Clin Oncol Educ Book 2018; 38 (38) 813-821
  • 40 Rogers SN, Thomson F, Lowe D. The Patient Concerns Inventory integrated as part of routine head and neck cancer follow-up consultations: frequency, case-mix, and items initiated by the patient. Ann R Coll Surg Engl 2018; 100 (03) 209-215
  • 41 Rehabilitation 2030 [Internet]. Accessed November 11, 2021 at: https://www.who.int/initiatives/rehabilitation-2030